Case Presentation: Fevers, Night Sweats, and Dyspnea

PulmPEEPs

D. Furfaro, K. Montemayor, E. Fridenmaker

Riliprubart in CIDP

Richard Lewis

Impact of the Updated Chronic Inflammatory Demyelinating Polyneuropa…

Suraj Muley

Inflammatory Neuropathies: Autoantibody Testing

University of Miami

N. Carberry

Autoimmune Neuropathies

University Hospitals

T. Bertorini

Multiple Sclerosis Treatment

ZINCARE

M. Chomba

ECTRIMS 2024 Insights: Real-World Evidence on Infection-Related Hosp…

Afagh Garjani

HIV and the Nervous System - 2024 Updates

ZINCARE

F. Mutete

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

Use of Advanced Imaging and AI in Diagnosis and Treatment of Multipl…

Houston Methodist

A. R. Alchaki

Overview of Neuromuscular Disorders

ZINCARE

S. Zimba

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

Paramagnetic Rim Lesions Predict Greater Long-Term Relapse Rates and…

Jack A. Reeves

Dry Needling & High Tech Mobility Devices for the Lower Extremity

Cleveland Clinic Neurological Institute

A. Gaglione

Therapeutic Approaches for Multiple Sclerosis: What We Know and What…

Cleveland Clinic Nevada

C. Hersh